Immunomodulation as a Potent COVID-19 Pharmacotherapy: Past, Present and FutureDecsa Medika Hertanto, Citrawati Dyah Kencono Wungu, Bayu Satria Wiratama et al.|Journal of Inflammation Research|2021Cited by 44
Modulating the host immune response to fight against COVID-19: Where are we in 2021?Decsa Medika Hertanto, Citrawati Dyah Kencono Wungu, Henry Sutanto et al.|Virulence|2021Cited by 9
Immunomodulation as a Potent COVID-19 Pharmacotherapy: Past, Present and FutureDecsa Medika Hertanto, Citrawati Dyah Kencono Wungu, Bayu Satria Wiratama et al.|Preprints.org|2021Cited by 6
Efficacy, safety, and immunogenicity of rurioctocog alfa pegol for prophylactic treatment in previously treated patients with severe hemophilia A: a systematic review and meta-analysis of clinical trialsBendix Samarta Witarto, Citrawati Dyah Kencono Wungu, Visuddho Visuddho et al.|F1000Research|2022Cited by 3
Efficacy safety and immunogenicity of rurioctocog alfa pegol for prophylactic treatment in previously treated patients with severe hemophilia A: a systematic review and meta-analysis of clinical trialsBendix Samarta Witarto, Citrawati Dyah Kencono Wungu, Visuddho Visuddho et al.|F1000Research|2021Cited by 3